Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 8/2018

01-08-2018 | Cornea

Corneal crosslinking (CXL) with 18-mW/cm2 irradiance and 5.4-J/cm2 radiant exposure—early postoperative safety

Authors: Isaak Fischinger, Theo G. Seiler, Karthiga Santhirasegaram, MD, Moritz Pettenkofer, Chris P. Lohmann, Daniel Zapp

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 8/2018

Login to get access

Abstract

Purpose

To investigate safety of accelerated corneal crosslinking during the first postoperative month.

Methods

In this retrospective study, 76 eyes of 60 patients with verified progressive keratectasia were enrolled in this study and followed for 1 month after accelerated CXL (18 mW/cm2 for 5 min, radiant exposure 5.4 J/cm2) (A-CXL(5*18)). Preoperatively, objective refraction, slit lamp inspection, and corneal tomography were performed. Early postoperative slit lamp examinations were performed on days 1 and 4. At 1 month, objective refraction, slit lamp inspection, and corneal tomography were performed.

Results

Gender distribution was m:f = 55:21, OD:OS was 40:36, and the average age was 26.5 ± 8.6 years at surgery. Only 71 of the 76 eyes completed the 1-month follow-up, indicating a dropout rate of 6.6%. In 7.0% (n = 5), sterile infiltrates were observed; 5.6% of eyes (n = 4) showed delayed epithelial healing (> 4 days) in 2.8% (n = 2); an infection occurred and in 1 eye (1.4%), a stromal scar was detected; no other complications, neither a loss of two or more Snellen lines at 1 month postoperatively, were observed. As a risk factor for sterile infiltrates, thin preoperative pachymetry could be identified (p = 0.027).

Conclusions

This study revealed no difference in early postoperative safety between CXL using 18 mW/cm2 and standard corneal CXL. Thinner preoperative pachymetry could be identified predicting a higher rate of postoperative sterile infiltrates.
Appendix
Available only for authorised users
Literature
1.
Seiler T, Spoerl E, Huhle M, Kamouna A (1996) Conservative therapy of keratoconus by enhancement of collagen cross-links. Invest Ophthalmol Vis Sci 37:1017
2.
Spoerl E, Huhle M, Kasper M, Seiler T (1997) Artificial stiffening of the cornea by induction of intrastromal cross-links. Ophthalmologe 94:902–906CrossRef
3.
Koller T, Mrochen M, Seiler T (2009) Complication and failure rates after corneal crosslinking. J Cataract Refract Surg 35(8):1358–1362CrossRef
4.
Caporossi A, Baiocchi S, Mazzotta C, Traversi C, Caporossi T (2006) Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen: preliminary refractive results in an Italian study. J Cataract Refract Surg 32(5):837–845CrossRef
5.
Raiskup F, Theuring A, Pillunat LE, Spoerl E (2015) Corneal collagen crosslinking with riboflavin and ultraviolet-A light in progressive keratoconus: ten-year results. J Cataract Refract Surg 41(1):41–46CrossRef
6.
Seiler TG, Schmidinger G, Fischinger I, Koller T, Seiler T (2013) Complications of corneal cross-linking. Ophthalmologe 110(7):639–644CrossRef
7.
Mazzotta C, Traversi C, Paradiso AL, Latronico ME, Rechichi M (2014) Pulsed light accelerated crosslinking versus continuous light accelerated crosslinking: one-year results. J Ophthalmol 2014:604731CrossRef
8.
Mita M, GOt W, Tomita M (2014) High-irradiance accelerated collagen crosslinking for the treatment of keratoconus: six-month results. J Cataract Refract Surg 40(6):1032–1040CrossRef
9.
Ehmke T, Seiler TG, Fischinger I, Ripken T, Heisterkamp A, Frueh BE (2016) Comparison of corneal riboflavin gradients using dextran and HPMC solutions. J Refract Surg 32(12):798–802CrossRef
10.
Chow VW, Chan TC, Yu M, Wong VW, Jhanji V (2015) One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Sci Rep 5:14425CrossRef
11.
Hashemi H, Fotouhi A, Miraftab M, Bahrmandy H, Seyedian MA, Amanzadeh K, Heidarian S, Nikbin H, Asgari S (2015) Short-term comparison of accelerated and standard methods of corneal collagen crosslinking. J Cataract Refract Surg 41(3):533–540CrossRef
12.
Tomita M, Mita M, Huseynova T (2014) Accelerated versus conventional corneal collagen crosslinking. J Cataract Refract Surg 40(6):1013–1020CrossRef
13.
Koller T, Iseli HP, Hafezi F, Vinciguerra P, Seiler T (2009) Scheimpflug imaging of corneas after collagen cross-linking. Cornea 28(5):510–515CrossRef
14.
Kymionis GD, Grentzelos MA, Kankariya VP, Liakopoulos DA, Portaliou DM, Tsoulnaras KI, Karavitaki AE, Pallikaris AI (2014) Safety of high-intensity corneal collagen crosslinking. J Cataract Refract Surg 40(8):1337–1340CrossRef
15.
Gatzioufas Z, Richoz O, Brugnoli E, Hafezi F (2013) Safety profile of high-fluence corneal collagen cross-linking for progressive keratoconus: preliminary results from a prospective cohort study. J Refract Surg 29(12):846–848CrossRef
16.
Lam FC, Georgoudis P, Nanavaty MA, Khan S, Lake D (2014) Sterile keratitis after combined riboflavin-UVA corneal collagen cross-linking for keratoconus. Eye 28(11):1297–1303CrossRef
17.
Raiskup F, Hoyer A, Spoerl E (2009) Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J Refract Surg 25(9):S824–S828CrossRef
18.
Çerman E, Özcan DÖ, Toker E (2017) Sterile corneal infiltrates after corneal collagen cross-linking: evaluation of risk factors. Acta Ophthalmol 95:199–204CrossRef
19.
Shetty R, Pahuja NK, Nuijts RM, Ajani A, Jayadev C, Sharma C, Nagaraja H (2015) Current protocols of corneal collagen cross-linking: visual, refractive, and tomographic outcomes. Am J Ophthalmol 160(2):243–249CrossRef
20.
Chan TC, Chow VW, Jhanji V, Wong VW (2015) Different topographic response between mild to moderate and advanced keratoconus after accelerated collagen cross-linking. Cornea 34(8):922–927CrossRef
21.
Raiskup F, Spoerl E (2013) Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. The ocular surface 11(2):65–74CrossRef
22.
Richoz O, Hammer A, Tabibian D, Gatzioufas Z, Hafezi F (2013) The biomechanical effect of corneal collagen cross-linking (CXL) with riboflavin and UV-A is oxygen dependent. Translational Vision Science & Technology 2(7):6CrossRef
23.
Kymionis GD, Tsoulnaras KI, Grentzelos MA, Plaka AD, Mikropoulos DG, Liakopoulos DA, Tsakalis NG, Pallikaris IG (2014) Corneal stroma demarcation line after standard and high-intensity collagen crosslinking determined with anterior segment optical coherence tomography. J Cataract Refract Surg 40(5):736–740CrossRef
24.
Brittingham S, Tappeiner C, Frueh BE (2014) Corneal cross-linking in keratoconus using the standard and rapid treatment protocol: differences in demarcation line and 12-month outcomes. Invest Ophthalmol Vis Sci 55(12):8371–8376CrossRef
25.
Hammer A, Richoz O, Arba Mosquera S, Tabibian D, Hoogewoud F, Hafezi F (2014) Corneal biomechanical properties at different corneal cross-linking (CXL) irradiances. Invest Ophthalmol Vis Sci 55(5):2881–2884CrossRef
26.
Seiler TG, Fischinger I, Senfft T, Schmidinger G, Seiler T (2014) Intrastromal application of riboflavin for corneal crosslinking. Invest Ophthalmol Vis Sci 55(7):4261–4265CrossRef
Metadata
Title
Corneal crosslinking (CXL) with 18-mW/cm2 irradiance and 5.4-J/cm2 radiant exposure—early postoperative safety
Authors
Isaak Fischinger
Theo G. Seiler
Karthiga Santhirasegaram, MD
Moritz Pettenkofer
Chris P. Lohmann
Daniel Zapp
Publication date
01-08-2018
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 8/2018
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-018-3978-9

Other articles of this Issue 8/2018

Graefe's Archive for Clinical and Experimental Ophthalmology 8/2018 Go to the issue

Retinal Disorders

Vitreomacular interface abnormalities in patients with diabetic macular oedema and their implications on the response to anti-VEGF therapy

Retinal Disorders

Vessel density, retinal thickness, and choriocapillaris vascular flow in myopic eyes on OCT angiography

Review Article

Current perspectives on corneal collagen crosslinking (CXL)

Letter to the Editor

The role of optical coherence tomography angiography in diagnosis of polypoidal choroidal vasculopathy

Glaucoma

Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results

Glaucoma

OCTA vessel density changes in the macular zone in glaucomatous eyes